Moderna Signs US$1.8 B Oncology Collaboration with Immatics
By Lucy Haggerty
Pharma Deals Review: Vol 2023 Issue 9 (Table of Contents)
Published: 15 Sep-2023
DOI: 10.3833/pdr.v2023.i9.2804 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In an attempt to diversify its portfolio, Moderna has entered into a strategic multi-platform collaboration with Immatics to develop new therapies for cancer patients with high unmet need...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS